Abstract
Understand the pharmacokinetics and pharmacodynamics of various sedative/hypnotics and analgesics. Be aware of the action of sedative/hypnotics and analgesics on central γ-aminobutyric acid (GABA) and opioid receptor systems. Understand the need for routine and effective sedation and analgesia in the critically ill patient. Make recommendations regarding the choice and appropriate dose of sedative/hypnotics and analgesics in the critically ill. Recognize that agitation has multiple etiologies and should be investigated as fully as possible prior to treatment. Recognize that agitated patients could pose danger to themselves and/or healthcare personnel, and pharmacologic intervention may be necessary to facilitate safe patient care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Coakley JH. Muscle relaxants and neuromuscular disorders in the intensive care unit. Baillieres Clin Anaesthesiol. 1994;8(2): 483-499.
Shelly MP, Mendel L, Park GR. Failure of critically ill patients to metabolize midazolam. Anaesthesia. 1987;42:619-626.
Malacrida R, Fritz ME, Suter PM, Crevoisier C. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med. 1992;20:1123-1126.
Wagner BKJ, O’Hara DA. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Clin Pharmacokinet. 1997;33:426-453.
Weissman C. The metabolic response to stress: an overview and update. Anesthesiology. 1990;73:308-327.
Kehlet H. The stress response to anesthesia: release mechanisms and modifying factors. Clin Anesthesiol. 1984;2:315.
Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg. 1988;67:329-337.
Angst MS, Clark JD. Opioid-induced hyperalgesia: a quantitative systematic review. Anesthesiology. 2006;104:570-587.
Cammarano WB, Pittet JF, Weitz S, et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998;26:676-684.
Hill HF, Chapman CR, Saeger LS, et al. Steady-state infusions of opioids in human: concentration-effect relationships and therapeutic margins. Pain. 1990;43:69-79.
Hansen-Flaschen JH, Brazinsky S, Basile C, et al. Use of sedating and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA. 1991;226:2870.
Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics, and paralytics in the ICU. Ann Pharmacother. 1997;31:148-153.
Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol. 1993;16:1-18.
Bentley JB, Borel JD, Nenad RE, Gillespie TJ. Age and fentanyl pharmacokinetics. Anesth Analg. 1982;61:968-971.
Jacobi J, Fraser G, Coursin D, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-141.
Macintyre PE, Pavlin EG, Dwersteg JF. Effect of meperidine on oxygen consumption, carbon dioxide production and respiratory gas exchange in postanesthesia shivering. Anesth Analg. 1987; 66:751-755.
Stambaugh JE, Wainer IW, Stanstead JK, et al. The clinical pharmacology of meperidine; comparison of routes of administration. J Clin Pharmacol. 1976;16:245-256.
Morgan D, Cook CD, Smith MA, Picker MJ. An examination of the interactions between the antinociceptive effects of morphine and various μ-opioids: the role of intrinsic efficacy and stimulus intensity. Anesth Analg. 1999;88:407-413
Wang JJ, Tai S, Lee ST, Liu YC. A comparison among nalbuphine, meperidine and placebo for treating postanesthetic shivering. Anesth Analg. 1999;88:686-689.
Yee JP, Koshiver JE, Allbon C, et al. Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery. Pharmacotherapy. 1986;6:253-261.
Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995;42:891-903.
Major CP, Greer MS, Russell WL, Roe SM. Postoperative pulmonary complications and morbidity after abdominal aneurysmectomy: a comparison of postoperative epidural versus parenteral opioid analgesia. Am Surg. 1996;62:45-51.
Rawal N, Schott U, Dahlstrom B, et al. Influence of naloxone infusion on analgesia and respiratory depression following epidural morphine. Anesthesiology. 1986;64:194-201.
Cohen SE, Ratner EF, Kreitzman TR, et al. Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg. 1992;75:747-752.
Pellecchia DJ, Bretz KA, Barnette RE. Post-operative pain control by means of epidural narcotics in a patient with obstructive sleep apnea. Anesth Analg. 1987;66:280-282.
Majid AA, Hamzah H. Pain control after thoracotomy. Chest. 1992;101:981-984.
Cohen SP, Christo PJ, Moroz L. Pain management in trauma patients. Am J Phys Med Rehabil. 2004;83:142-161.
Ben-David B, Merman R, Chelly JE. Paravertebral blocks in thoracoscopy: single no, continuous yes. Anesthesiology. 2007;106(2): 398.
Bergman B, Hebl J, Kent J, et al. Neurologic complications of 405 consecutive continuous axillary catheters. Anesth Analg. 2003;96(1):247-252.
Bouaziz H. Complications of regional anesthesia. Anesthesiology. 2000;92(6):1858.
Candido K, Sukhani R, Doty R, et al. Neurologic sequelae after interscalene brachial plexus blocks for shoulder/upper arm surgery: the Association of Patient, Anesthetic, and Surgical Factors to the Incidence and Clinical Course. Anesth Analg. 2005;100(5):1489-1495.
Chelly J, Casati A, Al-Samsam T, et al. Continous lumbar plexus block for acute postoperative pain management after open reduction and internal fixation of acetabular fractures. J Orth Trauma. 2003;17(5):362-367.
Liu S, Salinas F. Continuous plexus and peripheral nerve blocks for postoperative analgesia. Anesth Analg. 2003;96(1):263-272.
Lee L, Posner K, Domino K, et al. Injuries associated with regional anesthesia in the 1980s and 1990s: A closed claims analysis. Anesthesiology. 2004;101(1):143-152.
Maiwand O, Makey AR. Cryoanalgesia for relief of pain after thoracotomy. BMJ.1980;282:1749-1750.
Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88(4):1071-1075.
Weinberg G, Ripper R, Feinstein D, Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28(3):198-202.
Weinberg GL, Ripper R, Murphy P, et al. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med. 2006;31(4): 296-303.
Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006; 105(1):217-218.
McCutchen T, Gerancher JC. Early intralipid therapy may have prevented bupivacaine-associated cardiac arrest. Reg Anesth Pain Med. 2008;33:178-180.
Corcoran W, Butterworth J, William S, et al. Local anesthetic-induced cardiac toxicity: a survey of contemporary practice strategies among academic anesthesiology departments. Anesth Analg. 2006;103(5):1322-1326.
Cohen M. IV Lipid emulsion for bupivacaine toxicity. Hosp Pharm. 2007;42:99-102
Greensmith JE, Murray WB. Complications of regional anesthesia. Curr Opin Anesth. 2006;19:531-537.
Devlin JW, Boleski G, Mlynarek M, et al. Motor activity assessment scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999;27:1271-1275.
Glass PS, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology. 1997;86(4):836-847.
Schwartz RD. The GABA-A receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem Pharm. 1988;37:3369.
Zorumski CF, Isenberg KE. Insights into the structure and function of GABA-Benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry. 1991;148:162.
Bruun-Meyer SE. The GABA/benzodiazepine receptor-chloride ionophore complex: nature and modulation. Prog Neuro-Psychopharmacol Biol Psychiat. 1987;11:365.
Power KG, Jerrom DWA, Simpsom RJ. Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalized anxiety. BMJ. 1985;290:1246.
Reves JG, Fragen RJ, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology. 1985;62:310.
Greenblatt DJ, Shader RI, Abernethy DR. Current status of benzodiazepines. N Engl J Med. 1983;309:354.
Bauer TM, Ritz R, Haberthür C, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995;346:145-147.
Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med. 1998;26:947-956.
Marinella MA. Propofol for sedation in the intensive care unit: essentials for the clinician. Respir Med. 1997;91:505-510.
Wagner BKJ, Zavotsky KE, Sweeney JB, Palmeri BA, Hammond JS. Patient recall of therapeutic paralysis in a surgical critical care unit. Pharmacotherapy. 1998;18:358-363.
Badr AE, Mychaskiw G, Eichhorn JH. Metabolic acidosis associated with a new form of propofol. Anesthesiology. 2001;94: 536-538.
Rosen DJ, Nicoara A, Koshy N, Wedderburn RV. Too much of a good thing? Tracing the history of the propofol infusion syndrome. J Trauma. 2007;63(2):443-447.
Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62(7):690-701.
Lowrey TS, Dunlap AW, Brown RO, Dickerson RN, Kudsk KA. Pharmacologic influence on nutrition support therapy: use of propofol in a patient receiving combined enteral and parenteral nutrition support. Nutr Clin Prac. 1996;11:147-149.
Harris CE, Grounds RM, Murray AM, Lumley J, Royston D, Morgan M. Propofol for the long term sedation in the intensive care unit. Anesthesia. 1990;45:366-372.
Park GR, Manara AR, Mendel L, Bateman PE. Ketamine infusion: its use as a sedative, inotrope and bronchodilator in a critically ill patient. Anaesthesia. 1987;42:980-983.
Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med. 1996;27(2):170-175.
Christ G, Mundigler G, Merhaut C, et al. Adverse cardiovascular effects of ketamine infusion in patients with catecholamine-dependent heart failure. Anaesth Intens Care. 1997;25:255-259.
Kolenda H, Gremmelt A, Rading S, Braun U, Markakis E. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir. 1996;138:1193-1199.
Liu LL, Gropper MA. Postoperative analgesia and sedation in the adult intensive care unit: a guide to drug selection. Ther Prac. 2003;63(8):755-767.
Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med. 2003;114:742-752.
Ickeringill M, Shehabi Y, Adamson H, Ruettimann U. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation. Haemodynamic effects and efficacy. Anaesth Inten Care. 2004;32:741-745.
Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother. 2007;41(2):245-252.
Johnston RG, Noseworthy TW, Friesen EG, et al. Isoflurane therapy for status asthmaticus in children and adults. Chest. 1990;97:698-701.
Kofke WA, Young RSK, Davis P, et al. Isoflurane for refractory status epilepticus. Anesthesiology. 1989;71:653.
Miller LR, Drummond JC, Lamond RG. Refractory arterial and intracranial hypertension in the intensive care unit: successful treatment with isoflurane. Anesthesiology. 1991;74(5):946.
Fricchione G, Kohane DS, Daly R, Todres ID. Psychopharmacology in the intensive care unit. New Horiz. 1998;6:353-362.
Adams F. Emergency intravenous sedation of the delirious medically ill patient. J Clin Psychiatry. 1988;49(12 suppl):22.
Tesar GE, Stern TA. Rapid tranquilization of the agitated intensive care unit patient. J Intensive Care Med. 1988;3:195.
Vinik HR, Bradley EL, Kissin I. Triple anesthetic combination: propofol-midazolam-alfentanil. Anesth Analg. 1994;78:354-358.
Csernansky JG, Mahmoud R, Brenner R, et al. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Eng J Med. 2002;346(18):1424.
Kane JM, Eerdekens M, Lindenmayer JP, et al. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry. 2003;160:1125.
Motsinger CD, Perron GA, Lacy TJ. Use of atypical antipsychotic drugs in patients with dementia. AAFP. 2003;67(11):2335.
Shapiro JM, Westphal LM, White PF, et al. Midazolam infusion for sedation in the intensive care unit: effect on adrenal function. Anesthesiology. 1986;64:394.
Additional Reading
Cammarano WB, Pittet JF, Weitz S, et al. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998;26:676-684.
Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995;42:891-903.
Devlin JW, Boleski G, Mlynarek M, et al. Motor activity assessment scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999;27:1271-1275.
Marinella MA. Propofol for sedation in the intensive care unit: essentials for the clinician. Respir Med. 1997;91:505-510.
Morgan D, Cook CD, Smith MA, Picker MJ. An examination of the interactions between the antinociceptive effects of morphine and various opioids: the role of intrinsic efficacy and stimulus intensity. Anesth Analg. 1999;88:407-413.
Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol. 1993;16:1-18.
Shapiro B, Warren J, Egol A, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med. 1995;23:1596-1600.
Wagner BKJ, O’Hara DA. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Clin Pharmacokinet. 1997;33:426-453.
Wagner BKJ, Zavotsky KE, Sweeney JB, Palmeri BA, Hammond JS. Patient recall of therapeutic paralysis in a surgical critical care unit. Pharmacotherapy. 1998;18:358-363.
Wang JJ, Tai S, Lee ST, Liu YC. A comparison among nalbuphine, meperidine and placebo for treating postanesthetic shivering. Anesth Analg. 1999;88:686-689.
Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics, and paralytics in the ICU. Ann Pharmacother. 1997;31:148-153.
Zorumski CF, Isenberg KE. Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry. 1991;148:162-173.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Barnette, R.E., Kim, D.Y., Schweiger, J.W., Criner, G.J. (2010). Use of Analgesics and Sedatives in Critical Care. In: Criner, G., Barnette, R., D'Alonzo, G. (eds) Critical Care Study Guide. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77452-7_57
Download citation
DOI: https://doi.org/10.1007/978-0-387-77452-7_57
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-77327-8
Online ISBN: 978-0-387-77452-7
eBook Packages: MedicineMedicine (R0)